IVI Partners with AcademyHealth to Address Economic Impacts on Patients and Caregivers

IVI, in partnership with AcademyHealth, released a joint report, “A Research Framework to Understand the Full Range of Economic Impacts on Patients and Caregivers,” for researchers, value assessors, and other decision-makers to address the full range of economic impacts on patients. This report was made possible through funding support from the Eugene Washington PCORI [...]

2023-06-01T15:08:05-04:00June 1st, 2023|News|

IVI Comments on CMS’ Medicare Drug Price Negotiation Program

IVI submitted comments on the Centers for Medicare and Medicaid Services' (CMS) initial guidance for the implementation of the Medicare Drug Price Negotiation Program (Medicare DPNP). We appreciate the opportunity to provide comment on this important issue. Read our full comments here. ### About IVI The Innovation and Value Initiative (IVI) is a [...]

2023-04-27T13:33:51-04:00April 27th, 2023|News|

IVI Co-Authors Manuscript with the RAND Corporation

IVI is pleased to share our recently published manuscript, co-authored with the RAND Corporation, in the Journal of Comparative Effectiveness Research. For this manuscript, IVI collaborated with a steering committee and surveyed patients with rheumatoid arthritis (RA) to discover a new method for engaging patients in healthcare valuation using patient-specific goals. The findings indicated [...]

2023-04-06T17:39:23-04:00April 6th, 2023|News|

IVI Statement in Response to ICER’s Health Equity Report

The Innovation and Value Initiative (IVI) has issued the following statement in response to the Institute for Clinical and Economic Review (ICER)'s recently published white paper, "Advancing Health Technology Assessment Methods that Support Health Equity." IVI commends some of the practical learnings and supports ICER on the exploration of how "[health technology assessment] HTA [...]

2023-03-19T13:24:34-04:00March 17th, 2023|News|

4th Annual IVI Methods Summit

Hear from industry though leaders including CMS, PCORI, researchers, payers, employers, and patient advocates as they come together to provide meaningful dialogue, insight, solutions and continue working toward answering the question: How can we center equity in healthcare? Keynote Speakers: Dora Hughes, Nakela Cook, and Donna Cryer What: 4th Annual IVI Methods Summit: Rewriting the [...]

2023-03-12T18:02:59-04:00March 8th, 2023|News|

IVI Presents Poster at 2022 PCORI Annual Meeting

IVI Chief Science Officer, Rick Chapman, PhD, presented at the 2022 PCORI Annual Meeting. The presentation focused on incorporating patient priorities in patient-centered outcomes research/comparative effectiveness research (PCOR/CER) and value assessment. View the poster presentation here. Additional information on the project is available here.

2022-12-06T16:13:56-05:00December 6th, 2022|News|

IVI’s CEO, Jason Spangler, Sits Down with Inside Health Care to Discuss “Value”

In the health care world, we talk about “value-based care” in terms of putting patients first, listening to patients’ stories and giving thoughtful input. Sometimes we talk about “value-based payment models”—where providers and clinicians are encouraged to base their payment drivers on achieving positive patient outcomes rather than on a purely financial basis. IVI CEO, [...]

2022-11-08T14:50:11-05:00November 8th, 2022|News|

IVI Publishes Article in The Patient on Preferences for Treatments for MDD

IVI recently published a paper in The Patient – Patient-Centered Outcomes Research describing the formative research undertaken by the project team to elicit qualitative and quantitative patient input in the disease state of major depressive disorder (MDD). Based on the PAVE patient-informed value element set, the project team first identified six key factors that [...]

2022-10-05T13:19:31-04:00October 5th, 2022|News|

HealthCore/IVI AMCP Nexus Poster

While several studies have examined real-world pharmacologic treatment patterns and costs among major depressive disorder (MDD) patients, few have examined the use of non-pharmacologic treatments. IVI recently conducted a study alongside HealthCore to describe the prevalence and predictors of treatment modality, healthcare resource utilization, and costs for newly diagnosed MDD patients. Commercially-insured US adult [...]

2022-10-05T13:10:06-04:00October 5th, 2022|News|
Go to Top